DeutschNewstral
Article
The Times of India on 2020-04-22 23:19
Covid-19: Mumbai firm seeks regulator nod for ARV trials
Related news
China begins clinical trials for new ARV to treat coronavirusvanguardngr.com- Serum gets DCGI nod for Phase 2 & 3 trialsThe Times of India
Corbevax, Covaxin get drug regulator nod for use in childrenThe Hindu- Mumbai company set to get nod to raze Noida twin towersThe Times of India
- HC orders K'taka to pay Mumbai firm for promo videoThe Times of India
- DCGI nod for Covaxin human trialsThe Hindu
Coal power firm seeking regulator nodnation.co.ke- Covid vaccine: Ahmd co gets nod for human trialsThe Times of India
China joint infrastructure projects get nod to issue securities: regulatormetro.us- Feluda, first desi Covid detector, gets regulator nodThe Times of India
- Nod to Serum Institute for trials of Oxford vaccineThe Times of India
- Reliance gets nod to start Covid vaccine trialsThe Times of India
Brazil’s health regulator suspends Chinese-made vaccine trialstimesofisrael.com- DCGI nod for Glenmark Pharma clinical trials on Favipiravir antiviral tablets for COVID-19 patientsThe Hindu
- Govt. gives TSPs nod for 5G trials; Chinese tech giants left outThe Hindu
- UK firm gets nod for $2b Kenyan damvanguardngr.com
- Johnson and Johnson seeks nod for vaccine trials on 12-17 age groupThe Hindu
- Covid vaccine: Nod for human trials marks beginning of end, says CentreThe Times of India
- DCGI gives nod to Bharat Biotech for intranasal booster dose trialsThe Hindu